Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Jul-Aug;47(7-8):984-92.
doi: 10.1345/aph.1S050. Epub 2013 Jun 18.

Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults

Affiliations
Randomized Controlled Trial

Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults

Wei-Hsuan Lo-Ciganic et al. Ann Pharmacother. 2013 Jul-Aug.

Abstract

Background: The impact of evidence-based guidelines and controlled trial data on use of cholesterol-lowering medications in older adults is unclear.

Objective: To examine whether utilization patterns of cholesterol-lowering medications in community-dwelling older adults changed following the release of the National Cholesterol Education Program Adult Treatment Panel III guidelines and results from the Prospective Study of Pravastatin in the Elderly at Risk in 2002.

Methods: Community-dwelling elderly individuals who were enrolled in the Health, Aging and Body Composition Study in 1997-1998 were followed for up to 11 years. An interrupted time series analysis with multivariable generalized estimating equations (GEEs) was used to examine changes in level and trend in cholesterol-lowering medication use before and after 2002, adjusting for sociodemographics, health-related behaviors, and health status.

Results: Cholesterol-lowering medication use increased nearly 3-fold from 14.9% in 1997-1998 to 42.6% in 2007-2008, with statins representing the most common class used (87-94%). Multivariable GEE results revealed no significant difference in the level of cholesterol-lowering medication use after 2002 (adjusted OR 0.95; 95% CI 0.89-1.02). Multivariable GEE results revealed that trend changes in the rate of increase in cholesterol-lowering medication declined after 2002 (adjusted ratio of ORs 0.92; 95% CI 0.89-0.95).

Conclusions: The use of cholesterol-lowering medication increased substantially over a decade in community-dwelling elderly individuals but was not related to a change in level or trend following the release of the guidelines and evidence-based data.

PubMed Disclaimer

Conflict of interest statement

CONFLICT STATEMENT: No conflicts of interest were reported.

Figures

Figure 1
Figure 1
Yearly Prevalence of Cholesterol-Lowering Medication Use by Four Groups from 1997–2008

References

    1. Schwartz JB, Zipes DP. Cardiovascular Disease in the Elderly. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Bonow: Braunwald’s Heart Disease - A Textbook of Cardiovascular Medicine. 9. Philadelphia, PA: Saunders, An Imprint of Elsevier; 2011. pp. 1727–57.
    1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association. Circulation. 2012;125:e2–e220. Epub 2011/12/20. 10.1161/CIR.0b013e31823ac046. - PMC - PubMed
    1. National Center for Health Statistics. Health, United States, 2010: With Special Features on Death and Dying. Hyattsville, MD: 2011. - PubMed
    1. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–98. Epub 2007/06/08. 10.1056/NEJMsa053935. - PubMed
    1. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Arch Intern Med. 1988;148:36–69. Epub 1988/01/01. - PubMed

Publication types

Substances